AAI members Gordon J. Freeman, Ph.D. (AAI ’01) and Arlene Helen Sharpe, M.D., Ph.D. (AAI ’96, president 2016–17) received the 2024 David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine from the National Academy of Medicine (NAM).
Dr. Freeman is Professor of Medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, and Dr. Sharpe is Kolokotrones University Professor at Harvard University and Chair of the Department of Immunology at Harvard Medical School.
They received the 2024 Hamburg Award for their breakthrough work identifying costimulatory pathways that control the activation and inhibition of T cell immune responses, leading to new, effective immunotherapies for cancer, autoimmune diseases, and transplant rejection. The award, which recognizes the recipients’ achievements with a medal and $50,000, was presented at the NAM’s annual meeting on October 20.
Find out more about Dr. Freeman’s research and Dr. Sharpe’s research.
Read the full award announcement.
